First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors
IDRX, Inc., a wholly owned subsidiary of GSK, LLC
IDRX, Inc., a wholly owned subsidiary of GSK, LLC
Revolution Medicines, Inc.
University Medical Center Groningen
Sumitomo Pharma America, Inc.
Revolution Medicines, Inc.
Celgene
H. Lee Moffitt Cancer Center and Research Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Swedish Medical Center
AVEO Pharmaceuticals, Inc.